Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Fischer

Plastic Surgery Philadelphia, PA Medical Doctor

NPI 1285869784 CMS profile 912987

51 N 39Th St, Dulles Building, Philadelphia, PA 19104

Open in the dashboard

General payments

$3,332,490

2,293 records reported · program years 2019–2025

Research payments

$7,871

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,100 paid to institutions, not to them · program year 2019

Through program year 2025, John Fischer of Philadelphia, PA is reported in the CMS Open Payments database as having received $3,332,490 across 2,293 general payments and $7,871 in research payments paid to them. Separately, studies naming them as principal investigator received $19,100 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $663,959 409
2024 General $685,829 456
2023 General $495,635 413
2022 General $472,521 328
2021 General $300,554 201
2020 General $159,059 108
2019 General $554,934 378
2019 Research $7,871 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Fischer
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to John Fischer were reported at $663,959. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year John Fischer Plastic Surgery median Middle half National median
2019 $554,934 $371 $122–$1,483 $163
2020 $159,059 $158 $52–$438 $114
2021 $300,554 $249 $87–$752 $132
2022 $472,521 $274 $102–$793 $149
2023 $495,635 $299 $113–$891 $160
2024 $685,829 $361 $124–$1,062 $164
2025 $663,959 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Davol Inc. $2,398,761 1,538 payments
  2. Integra LifeSciences Corporation $358,906 260 payments
  3. W. L. Gore & Associates, Inc. $319,795 251 payments
  4. Allergan Inc. $75,765 68 payments
  5. KCI USA, Inc $43,056 25 payments
  6. Baxter Healthcare $39,093 15 payments
  7. AbbVie, Inc. $31,833 26 payments
  8. Solventum Corporation $27,677 19 payments
  9. Bard Peripheral Vascular, Inc. $26,427 6 payments
  10. Becton, Dickinson and Company $6,201 43 payments
  11. Other $4,977 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $1,890,523 287 payments
  2. Consulting Fee $825,618 217 payments
  3. Travel and Lodging $380,739 990 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $176,581 48 payments
  5. Food and Beverage $58,999 750 payments
  6. Education $30 1 payment
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $138,038 117 payments
  2. Phasix Mesh $137,110 502 payments
  3. Integra Recon-Skin And Wound $136,977 109 payments
  4. GORE SYNECOR Biomaterial $131,445 60 payments
  5. FLOWABLE $117,975 77 payments
  6. INTEGRA WOUND MATRIX (IWM) $117,975 77 payments
  7. IDRT $117,975 77 payments
  8. BILAYER WOUND MATRIX (BWM) $117,975 77 payments
  9. SYNECOR Biomaterial $111,659 44 payments
  10. GORE BIO-A Tissue Reinforcement $85,820 78 payments
  11. Other $985,179 1,149 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Integra LifeSciences Corporation $7,871 1 payment

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$123,514

Medicare's payments for the services billed

Medicare patients

111

Average age 70

Services billed

458

69 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 50%
Diabetes 33%
Ischemic heart disease 31%
Depression 31%
Cancer 29%
Chronic kidney disease 23%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
IGALMI
$122 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

2,294 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record